Icosavax, Inc.
NASDAQ:ICVX
15.31 (USD) • At close February 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.732 | 1.827 | 1.904 | 2.001 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.763 | 0.665 | 0.643 | 1.602 | 0.143 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.763 | -0.665 | -0.643 | -1.602 | -0.143 | 0 | 0 | -5.732 | 1.827 | 1.904 | 2.001 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 16.668 | 19.826 | 17.357 | 16.193 | 15.484 | 15.82 | 17.913 | 14.063 | 10.883 | 8.277 | 5.553 | 5.329 | 4.752 | 4.666 | 2.92 |
| General & Administrative Expenses
| 8.607 | 9.129 | 9.165 | 8.938 | 7.659 | 7.311 | 6.322 | 6.218 | 25.357 | 2.221 | 1.091 | 0.802 | 0.704 | 0.541 | 0.612 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.607 | 9.129 | 9.165 | 8.938 | 7.659 | 7.311 | 6.322 | 6.218 | 25.357 | 2.221 | 1.091 | 0.802 | 0.704 | 0.541 | 0.612 |
| Other Expenses
| 0 | 0 | 0 | 0.582 | 0 | 0 | -0.582 | 0 | 0 | 0 | -0.205 | -1.616 | 0 | 0 | 0 |
| Operating Expenses
| 25.275 | 28.955 | 26.522 | 25.131 | 23.143 | 23.131 | 23.653 | 18.211 | 34.413 | 8.594 | 4.643 | 4.515 | 5.456 | 5.207 | 3.532 |
| Operating Income
| -25.275 | -28.955 | -26.522 | -25.131 | -23.143 | -23.131 | -23.653 | -18.211 | -34.413 | -8.594 | -4.643 | -4.515 | -5.456 | -5.207 | -3.532 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.177 | -18.836 | -4.514 | -2.32 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.234 | 2.458 | 1.961 | 1.518 | 1.167 | 0.495 | 0.12 | 0.029 | 0.027 | 0.042 | -1.208 | -0.093 | -0.121 | 0.009 | 0.061 |
| Income Before Tax
| -22.041 | -26.497 | -24.561 | -23.613 | -21.976 | -22.636 | -23.533 | -18.182 | -34.386 | -8.552 | -5.851 | -4.608 | -5.577 | -5.198 | -3.471 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.172 | -18.821 | -4.492 | -2.924 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.763 | -0.665 | -1.961 | -2.133 | -1.167 | -0.495 | -0.12 | 32.549 | 0 | 0 | 0.249 | 0 | 0 | 0 | 0 |
| Net Income
| -22.041 | -26.497 | -22.6 | -21.48 | -20.809 | -22.141 | -23.413 | -18.182 | -34.386 | -8.552 | -5.851 | -4.608 | -5.577 | -5.198 | -3.471 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.172 | -18.821 | -4.492 | -2.924 | 0 | 0 | 0 | 0 |
| EPS
| -0.44 | -0.59 | -0.55 | -0.54 | -0.52 | -0.56 | -0.59 | -0.46 | -1.3 | -2.86 | -1.96 | -1.6 | -1.87 | -1.74 | -0.23 |
| EPS Diluted
| -0.44 | -0.59 | -0.55 | -0.54 | -0.52 | -0.56 | -0.59 | -0.46 | -1.3 | -2.86 | -1.96 | -1.6 | -1.87 | -1.74 | -0.23 |
| EBITDA
| -25.275 | -28.955 | -26.522 | -25.131 | -23 | -23.076 | -23.61 | -18.211 | -34.384 | -8.578 | -4.642 | -4.514 | -5.456 | -5.207 | -3.532 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.177 | -18.82 | -4.505 | -2.32 | 0 | 0 | 0 | 0 |